Replies to post #15827 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

USPTO invalidates Teva's '302 patent on 40mg Copaxone:

down goes '302 $TEVA

— zach (@zbiotech) September 1, 2016

That makes 3 of 3 Teva patents invalidated by the PTO—the IPR; the other two are the '413 and '250 patents (#msg-124748552).